Brains Bioceutical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Announced)

  • Investors
  • 2

Brains Bioceutical General Information

Description

Developer of cannabidiol pharmaceutical ingredients designed to make pharmaceutical and wellness products for patients. The company's ingredients prepare products that include plant-based cannabidiol oils, vitamins, sprays, creams, balms, and capsules that are tetrahydrocannabinol-free, non-genetically modified organisms and vegan, enabling patients to get full access to quality good manufacturing practices naturally sourced active pharmaceutical ingredients at affordable prices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Granville Square
  • 200 Granville Street
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (855)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Granville Square
  • 200 Granville Street
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brains Bioceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Reverse Merger 05-Nov-2026 Announced Clinical Trials - Phase 3
2. Later Stage VC 16-Jun-2021 Completed Generating Revenue
1. Later Stage VC 19-Dec-2019 $30M $30M Completed Pre-Clinical Trials
To view Brains Bioceutical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Brains Bioceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cannabidiol pharmaceutical ingredients designed to make pharmaceutical and wellness products for patients.
Other Pharmaceuticals and Biotechnology
Vancouver, Canada
21 As of 2026

Barrie, Canada
 

Vancouver, Canada
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Brains Bioceutical Competitors (4)

One of Brains Bioceutical’s 4 competitors is Canna Farms, a Corporate Backed or Acquired company based in Barrie, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canna Farms Corporate Backed or Acquired Barrie, Canada
Lotus Cannabis Company Corporation Vancouver, Canada
Fotmer Life Sciences Venture Capital-Backed Canelones, Uruguay
AXIM Biotechnologies Corporation New York, NY
To view Brains Bioceutical’s complete competitors history, request access »

Brains Bioceutical Patents

Brains Bioceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250114381-A1 Cannabinoid composition and uses thereof Inactive 04-Oct-2023

Brains Bioceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brains Bioceutical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
dsm-firmenich Ventures Corporate Venture Capital Minority
Canaccord Genuity Investment Bank Minority
To view Brains Bioceutical’s complete investors history, request access »

Brains Bioceutical Investments & Acquisitions (2)

Brains Bioceutical’s most recent deal was a Merger/Acquisition with Armada Acquisition III. The deal was made on 05-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Armada Acquisition III 05-Nov-2026 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
BTT Life Sciences Joint Venture Biotechnology
To view Brains Bioceutical’s complete investments and acquisitions history, request access »

Brains Bioceutical FAQs

  • When was Brains Bioceutical founded?

    Brains Bioceutical was founded in 2010.

  • Where is Brains Bioceutical headquartered?

    Brains Bioceutical is headquartered in Vancouver, Canada.

  • What is the size of Brains Bioceutical?

    Brains Bioceutical has 21 total employees.

  • What industry is Brains Bioceutical in?

    Brains Bioceutical’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Brains Bioceutical a private or public company?

    Brains Bioceutical is a Private company.

  • What is Brains Bioceutical’s current revenue?

    The current revenue for Brains Bioceutical is .

  • How much funding has Brains Bioceutical raised over time?

    Brains Bioceutical has raised $61.9M.

  • Who are Brains Bioceutical’s investors?

    dsm-firmenich Ventures and Canaccord Genuity have invested in Brains Bioceutical.

  • Who are Brains Bioceutical’s competitors?

    Canna Farms, Lotus Cannabis Company, Fotmer Life Sciences, and AXIM Biotechnologies are competitors of Brains Bioceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process